Status:
TERMINATED
Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques
Lead Sponsor:
University of California, Los Angeles
Conditions:
Face Pain
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Botulinum toxin-A (BTX-A) prevents the release of acetylcholine in presynaptic terminals of the neuromuscular junction. It has been proposed to be effective in spastic conditions of the head and neck ...
Eligibility Criteria
Inclusion
- Subjects are to have identifiable painful myofascial trigger points in the masseter, temporalis, and medial and lateral pterygoid muscles.
- Subjects will be examined by the principle investigators to determine if the individual is a suitable candidate for the study, based on active trigger points and willingness to participate in the study
Exclusion
- Pregnant woman will be excluded from participation as potential risk is noted in product label indications. Individuals over the age of 65 will be excluded per product label indications that reflect lack of data in individuals over age 65.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00992108
Start Date
October 1 2009
End Date
October 1 2010
Last Update
December 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Westwood Associates
Los Angeles, California, United States, 90024